Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis

MG Tektonidou - Journal of Autoimmunity, 2022 - Elsevier
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

[HTML][HTML] Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management

P Pignatelli, E Ettorre, D Menichelli, A Pani, F Violi… - …, 2020 - ncbi.nlm.nih.gov
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
arterial and venous thrombotic manifestations and/or pregnancy-related complications in …

Neutrophils and redox stress in the pathogenesis of autoimmune disease

L Glennon-Alty, AP Hackett, EA Chapman… - Free Radical Biology and …, 2018 - Elsevier
Polymorphonuclear leukocytes, or neutrophils, are specialist phagocytic cells of the innate
immune system. Their primary role is host defence against micro-organisms, which they kill …

Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19

JL Izquierdo, JB Soriano, Y González… - Science …, 2022 - journals.sagepub.com
Infection by SARS-CoV-2 causing coronavirus disease 2019 (COVID-19) can be associated
with serious and life-threatening conditions, including acute respiratory distress syndrome …

[HTML][HTML] Comparison of antioxidant capacity of cow and ewe milk kefirs

L Yilmaz-Ersan, T Ozcan, A Akpinar-Bayizit… - Journal of dairy …, 2018 - Elsevier
This research aimed to evaluate the effects of using either grain or commercial starter culture
on the antioxidative capacity of cow and ewe milk kefirs. The antioxidant capacity of kefir …

Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots

ML Tung, B Tan, R Cherian… - … advances in practice, 2021 - academic.oup.com
As the coronavirus disease 2019 (COVID-19) pandemic, which is caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly worldwide, it …

COVID-19 and antiphospholipid antibodies

A Butt, D Erkan, AI Lee - Best Practice & Research Clinical Haematology, 2022 - Elsevier
Antiphospholipid syndrome and the coagulopathy of COVID-19 share many
pathophysiologic features, including endotheliopathy, hypercoagulability, and activation of …

Endothelial function and endothelial progenitor cells in systemic lupus erythematosus

A Mak, JKY Chan - Nature Reviews Rheumatology, 2022 - nature.com
The observations that traditional cardiovascular disease (CVD) risk factors fail to fully
account for the excessive cardiovascular mortality in patients with systemic lupus …

Oxidative stress contributes to inflammatory and cellular damage in systemic lupus erythematosus: cellular markers and molecular mechanism

Z Yan, Q Chen, Y Xia - Journal of Inflammation Research, 2023 - Taylor & Francis
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with complex
pathogenesis, the treatment of which relies exclusively on the use of immunosuppressants …

Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus

J Rodríguez-Carrio, P López, B Sánchez… - Frontiers in …, 2017 - frontiersin.org
Metabolic impairments are a frequent hallmark of systemic lupus erythematosus (SLE).
Increased serum levels of free fatty acids (FFA) are commonly found in these patients …